Translational Development Unit (TDACU)
Featured in
Bullish Trend Stocks
Translational Development Acquisition Corp. is associated with NASDAQ-listed debt/equity composite units under the symbol TDAC.U. The issuer is a blank check company with no significant operating business of its own and was formed to pursue a future business combination through a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or a similar transaction. The company was incorporated in 2022 and is based in New York, New York. As a hybrid or composite unit security, TDAC.U reflects the listed instrument rather than an ordinary operating company.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | P/E Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-TDAC.U
|
$10.70
|
-7.7% Downside
|
Fair
|
Not available
|
Not available
|
Fair
|
0.0%
|
40.5x
|
242.7 M
|
225 M
|
0.5%
|
77.6%
|
0.7
|
-15.3%
|
